Biotech · Private company
Navire Pharma Inc., a BridgeBio company
Track this companyFree. Adds Navire Pharma Inc., a BridgeBio company to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BBP-398 (Formerly known as IACS-15509)Phase 1 · Tumor, SolidClinicalTrials.gov · fetched Nov 12, 2026
- BBP-398 with nivolumabPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS MutationPHASE1 · TERMINATED · started Oct 20, 2022ClinicalTrials.gov NCT05375084 · fetched Nov 12, 2026
- First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started Nov 12, 2020ClinicalTrials.gov NCT04528836 · fetched Nov 12, 2026